Update of diagnosis and treatment for male hypogonadism in children

doi:10.11852/zgetbjzz2018-26-06-02

Abstract

Abstract: Male hypogonadism in children is common in pediatric endocrineclinic,characterized by delayed puberty, gonadal dysgenesis and the hypofunction of hypothalamic-pituitary-gonadal axis. The causes of hypogonadism can be divided into 2 categories: primary hypogonadism and secondary hypogonadism(hypogonadotropic). Male hypogonadism in children and adolescents is common clinically, while hypogonadism in newborns and infants is often ignored. There still have been many disputes in the diagnosis and treatment of childhood hypogonadism. In this paper, the problem will be discussed in order to proride reference for pediatricians.

Key words: hypogonadism, newborns and infants, children and adolescents, male

摘要： 男童性腺功能低下在儿科内分泌临床较为常见,主要表现为青春期延迟,性发育不良和下丘脑-垂体-性腺轴功能低下。按病因分为两大类:原发性性腺功能低下和继发性性腺功能低下(低促性腺激素性性腺功能低下)。男性儿童及青少年常因性腺功能低下就诊于儿科内分泌临床,而新生儿期及婴幼儿期的性腺功能低下却往往被忽视。目前对男童性腺功能低下的诊断和处理存在不少争议和困难,本文就此问题进行讨论,期望对儿科临床医生有所帮助。

关键词: 性腺功能低下, 新生儿及婴幼儿, 儿童及青少年, 男性

CLC Number:

R179

LI Tang, HU Si-cui. Update of diagnosis and treatment for male hypogonadism in children[J]. journal1, 2018, 26(6): 584-586.

李堂, 胡思翠. 男童性腺功能低下的诊治进展[J]. 中国儿童保健杂志, 2018, 26(6): 584-586.

0
/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://manu41.magtech.com.cn/Jwk_zgetbjzz/EN/10.11852/zgetbjzz2018-26-06-02

https://manu41.magtech.com.cn/Jwk_zgetbjzz/EN/Y2018/V26/I6/584

References

[1] Sigalos JT, Pastuszak AW, Khera M.Hypogonadism: Therapeutic risks, benefits, and outcomes[J].Med Clin North Am, 2018,102(2):361-372.
[2] 卢忠啓. 青春发育异常[M].//颜纯,王慕逖. 小儿内分泌学. 2版. 北京:人民卫生出版社,2006: 285-343.
[3] Bertelloni S, Baroncelli GI, Garofalo P, et al. Androgen therapy in hypogonadal adolescent males[J]. Horm Res Paediatr,2010,74: 292-296.
[4] Yin A, Swerdloff R. Treating hypogonadism in younger males[J]. Expert Opin Pharmacother, 2010, 11(9):1529-1540.
[5] 朱逞. 性激素分泌功能试验[M]//颜纯,王慕逖. 小儿内分泌学. 2版. 北京:人民卫生出版社,2006,773-775.
[6] Radicioni AF, Ferlin A, Balercia G, et al. Consensus statement on diagnosis and clinical management of Klinefelter syndrome[J]. Endocrinol Invest,2010,33:839-850.
[7] Crumbach MM. A window of opportunity diagnosis of gonadotropin deficiency in the male infant[J].Clin Endocrinol Metab,2005,90(5):3122-3127.
[8] Chan E, Wayne C, Nasr A, et al. Ideal timing oforchiopexy: a systematic review[J].Pediatr Surg Int, 2014,30: 87-97.
[9] Bin-Abbas B, Conte FA,Grumbach MM,et al. Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated[J]. Pediatr,1999,134:579-583.
[10] Main KM, Schmidt IM, Toppari J,et al. Early postnatal treatment of hypogonadotropic hypogonadism[J]. Eur J Endocrinol, 2002,146:75-79.
[11] Bougneres P,Francois M,Pantalone L,et al.Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormone [J].Clin Endocrinol Metab,2008,93(6):2202-2205.
[12] Boehm U,Bouloux PM,Dattani MT,et al. European Consensus Statement on congenital hypogonadotropichypogonadism-pathogenesis, diagnosis and treatment[J].Nat Rev Endocrinol,2015,11:547-564.
[13] Han TS,Bouloux PMG.What is the optimal therapy for young males with hypogonadotropic hypogonadism?[J].Clin Endocrinol,2010,72(6):731-737.
[14] Krakowsky Y, Conners W, Davidson E, et al.Initial clinical experience with testosterone undecanoate therapy (AVEED) in men with testosterone deficiency in the united states[J].Urology,2017,109:27-31.
[15] Ramos L, Patel AS, Ramasamy R.Testosterone replacement therapy for physician assistants and nurse practitioners[J].Transl Androl Urol,2018,7(Suppl 1):63-71.